1,2,3,4-TETRAHYDRO-2-NAPHTHYLAMINE
- Product Name1,2,3,4-TETRAHYDRO-2-NAPHTHYLAMINE
- CAS2954-50-9
- CBNumberCB8699318
- MFC10H13N
- MW147.22
- EINECS220-973-7
- MDL NumberMFCD00045577
- MOL File2954-50-9.mol
- MSDS FileSDS
Chemical Properties
Melting point | 149-151 °C |
Boiling point | 257.35°C (rough estimate) |
Density | 1.0048 (rough estimate) |
refractive index | 1.5620 (estimate) |
RTECS | QM4900000 |
storage temp. | Refrigerator, under inert atmosphere |
solubility | Chloroform (Soluble, Sonicated), DMSO (Slightly), Methanol (Slightly) |
pka | 10.50±0.20(Predicted) |
form | Solid |
color | Dark Yellow to Very Dark Brown |
EWG's Food Scores | 1 |
FDA UNII | LGX8T83G7X |
Safety
Symbol(GHS) | ||||||||||
Signal word | Warning | |||||||||
Hazard statements | H315-H319-H335 | |||||||||
Precautionary statements | P261-P280a-P304+P340-P305+P351+P338-P405-P501a | |||||||||
Risk Statements | 36/37/38 | |||||||||
Safety Statements | 26-36/37/39 | |||||||||
Toxicity | dog,LDLo,intravenous,10mg/kg (10mg/kg),GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDSVASCULAR: REGIONAL OR GENERAL ARTERIOLAR CONSTRICTIONSENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE,Archives Internationales de Pharmacodynamie et de Therapie. Vol. 35, Pg. 70, 1928. | |||||||||
NFPA 704: |
|